Skip to main content
. 2022 Oct 31;30(4):574–583. doi: 10.5606/tgkdc.dergisi.2022.21975

Table 5. Distribution, intensity, overall score of TAK-1 and T factor subgroups on patients with SCC.

  TAK-1
  Distribution Intensity Overall score
  χ2= 9.264 χ2=24.815 χ2=22.099
Significance Cramer’s V=0.388
p= 0.099, p= 0.099
Cramer’s V=0.643
p<0.001, p<0.001
Cramer’s V=0.609
p<0.001, p<0.001
T factor 11-25% 26-50% >51% Slight yellow  Dark yellow Brown No staining (0-2)  Mild (3-4) Severe (5-6)
  n % n % n % n % n % n % n % n % n %
1A (n=2) 2 100,0 0 0,0 0 0,0 2 100,0 0 0,0 0 0,0 2 100,0 0 0,0 0 0,0
1B (n=8) 6 75,0 2 25,0 0 0,0 3 37,5 5 62,5 0 0,0 3 37,5 5 62,5 0 0,0
2A (n=16) 3 18,8 9 56,3 4 25,0 1 6,3 1 6,3 14 87,4 1 6,3 2 12,4 13 81,3
2B (n=9) 4 18,8 4 56,3 1 25,0 0 0,0 2 22,2 7 77,8 0          
TAK-1: Transforming growth factor (TGF)-β-activated kinase 1; SCC: Squamous cell carcinoma.